Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
Leniolisib has the potential for immunodeficiency disorders treatment
NFAT proteins will cooperate with other nuclear resident transcription factors due to that they have weak DNA-binding capacity
InChiKey: BSMCAPRUBJMWDF-KRWDZBQOSA-N
InChi: InChI=1S/C19H21N3O6/c23-14-9-8-13(17(26)21-14)22-18(27)11-5-4-6-12(16(11)19(22)28)20-10-3-1-2-7-15(24)25/h4-6
6-dihydrophenanthridin-8-yl)carbamate
SSTR5 antagonist 2 Catalog No.:M30061-C Leniolisib has the potential forSSTR5 antagonist 2 (compound 10) is a highly potent, oral active and selective somatostatin (receptor) subtype 5 (SSTR5) antagonist and has potential to treat type 2 diabetes mellitus (T2DM). Product information CAS Number: 1254730 81 8 Molecular Weight: 546. 63 Formula: C32H35FN2O5 Chemical Name: 4 [8 ({2,6 diethoxy 4' fluoro [1,1' biphenyl] 4 yl}methyl) 3 oxo 2,8 diazaspiro[4. 5]decan 2 yl]benzoic acid Smiles: